Association Between Atherogenic Index of Plasma, Body Mass Index, and Sarcopenia: A Cross-Sectional Study Based on Elderly Individuals in China
Bowen Lu,Jiacheng Li,Xuezhen Liang,Mingtao Wen,Di Luo,Haifeng Jia,Jiahao Zhang,Gang Li
DOI: https://doi.org/10.21203/rs.3.rs-4875214/v1
2024-01-01
Abstract:Objective: To investigate the correlation between the Atherogenic Index of Plasma (AIP), Body Mass Index (BMI), and sarcopenia in the elderly Chinese population, and to analyze the predictive ability of AIP and BMI for sarcopenia. Methods: A retrospective analysis was conducted on 3,709 eligible participants aged 60 and above, based on data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2015. The subjects were divided into a sarcopenia group (n=1449) and a non-sarcopenia group (n=2260). AIP and BMI were grouped by quartiles, and logistic regression models were used to analyze the relationship between these variables and the risk of sarcopenia. A restricted cubic spline regression model was used to analyze the dose-response relationship between different levels of AIP and BMI with sarcopenia. The predictive value of individual and combined indicators for sarcopenia was assessed using the Receiver Operating Characteristic (ROC) curve. Results: Univariate analysis showed that sarcopenia was associated with age, marital status, education level, place of residence, alcohol consumption, BMI, uric acid (UA), glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), AIP index, and the presence of hypertension, diabetes, dyslipidemia, chronic lung disease, liver disease, and digestive system diseases (p < 0.05). After adjusting for confounding factors, logistic regression analysis indicated that the 4th quartile of AIP index and BMI had the lowest risk of sarcopenia compared to the 1st, 2nd, and 3rd quartiles, with odds ratios of 0.46 (95% CI = 0.37–0.57) and 0.04 (95% CI = 0.03–0.05), respectively. The AIP index showed a clear linear dose-response relationship with sarcopenia, while BMI demonstrated a significant nonlinear dose-response curve, resembling an "L" shape. ROC curve analysis revealed that the combined predictive ability of AIP and BMI was superior to that of individual indicators, with an AUC of 0.7996. Conclusion: Elevated AIP index and BMI are closely associated with a reduced risk of sarcopenia, and both have certain predictive value for sarcopenia. Considering all factors, the combination of AIP and BMI is the optimal predictive indicator for sarcopenia.